CAPRICOR THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.195 USD | -0.08% |
|
+16.98% | +26.79% |
| May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
| May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 6.600 | 7.095 | 7.770 |
| Spread/Res. | -6.06% | -12.61% | -20.21% |
| Spread/Supp. | +28.63% | +39.33% | +127.94% |
| Support | 4.820 | 4.450 | 2.720 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CAPR Stock
- Charts Capricor Therapeutics, Inc.
